Home » Topics » BioWorld Science

BioWorld Science
RSS

Sanctura receives FDA approval

June 3, 2004

ND-1251 enters phase I for depression

June 3, 2004

Avigen to focus resources on neurological drug candidates

June 3, 2004

New phase II trial for Serostim in HARS

June 3, 2004

Successful synthesis of radiolabeled ENT-103

June 3, 2004

Preclinical safety and efficacy of chimeric yellow fever vaccine in non-human primates

June 3, 2004

Rigel's development programs proceeding according to plan

June 3, 2004

Pharmacyclics continues to advance multiple clinical development programs with Xcytrin

June 3, 2004

Array BioPharma highlights Q3 FY 2004 developments

June 3, 2004

Caspase -3 and -8 inhibition has therapeutic potential in lung transplantation

June 3, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...